The Barcelona Court has acquitted the orderly at Bellvitge Hospital accused of sexually abusing a patient in the eating disorders unit of the same center with a prognosis of severe anorexia. a case advanced by the ARA. The trial was held on January 26. And this Tuesday, ARA obtained access to the ruling that acquits OMV, for whom the prosecution had requested an eight-year prison sentence for repeated sexual abuse. The events date back to the summer of 2020.

The patient at Bellvitge Hospital with anorexia who accused a hospital orderly of abuse has reaffirmed her account of the various episodes of sexual assault she claims to have suffered. She did so this Monday during the first and last session of the trial held at the Barcelona Provincial Court. The orderly, sitting in the dock, denied the allegations and stated that he never had any physical contact with the patient, who was admitted to the eating disorder unit at Bellvitge, a center of the Catalan Health Institute (ICS) of the Generalitat of Catalonia. At the end of the trial, the prosecution requested a nine-year prison sentence for the orderly, a request that the private prosecution, representing the complainant, increased to ten years. The defense requested the defendant's acquittal. The ICS representative also denied any wrongdoing.

A hospital orderly at Bellvitge Hospital, OMV, will appear in court this week at the Barcelona Provincial Court as the alleged perpetrator of repeated sexual abuse of a patient. According to information obtained by ARA, the events date back to the summer of 2020, and the complainant, an adult, was hospitalized in the eating disorders unit at Bellvitge, a center of the Catalan Health Institute (ICS) of the Generalitat of Catalonia. She suffered from severe anorexia. In its indictment, the Public Prosecutor's Office is requesting a nine-year prison sentence for the orderly. The private prosecution, representing the complainant, is seeking a ten-year sentence. The ICS, which is subsidiarily liable for any future compensation, as well as the defendant's legal team, are requesting acquittal.

The Organization of European Cancer Institutes (OECI) has accredited the Bellvitge Health Campus as a Comprehensive Cancer Center (CCC), the highest European distinction in comprehensive cancer treatment. Until now, Vall d'Hebron was the only Catalan hospital to hold this seal, which only 44 centers in Europe hold. This seal sets the treatment standards to be followed by 2030. Bellvitge's service radius of two million people makes it the largest University CCC in Spain and the first formed by three public entities—the ICO and the ICO.

A team including the Bellvitge Biomedical Research Institute (IDIBELL) has launched a revolutionary project to exploit human genome data with artificial intelligence. The project is part of the Structural Genomics Consortium (SGC), a global public-private consortium made up of seven universities and nine pharmaceutical companies. The goal is to facilitate the discovery of the function of many of the proteins in the genome and thus accelerate the discovery of new drugs for diseases that still do not provide treatment.